Rutherford Health partners with precision medicine specialist

Proton beam and cancer treatment specialist Rutherford Health plc has partnered with OncoDNA to offer biomarker testing for patients. A genomic and theranostic company specialising in precision medicine, OncoDNA provides biomarker tests on solid and liquid biopsy to help oncologists and cancer patients identify the most effective forms of therapy and monitor disease progression.  Under the partnership,…

You must be a HM Subscriber to view this content.

Subscribe Now »